Back to Search
Start Over
A study to assess the co-morbidities and complications of polycystic ovarian syndrome
- Source :
- Cellular, Molecular and Biomedical Reports, Vol 3, Iss 2, Pp 107-113 (2023)
- Publication Year :
- 2023
- Publisher :
- Global Sciences, 2023.
-
Abstract
- The purpose of the study was to evaluate the prevalence, co-morbidities, pharmacological therapy, and effectiveness of common lifestyle changes for metabolic dysfunction in women with the polycystic ovarian syndrome (PCOS) and related comorbidities in the gynaecology division. This 6-month prospective observational study of 120 PCOS patients who were gynaecology patients at a tertiary care hospital was conducted from September 2021 to February 2022. An interview with the patient was done using an assessment form. This study highlighted the supportive evidence among PCOS patients for the advantages of changing one's lifestyle. This study involved 90 PCOS individuals out of a total of 120 participants, many of them were in the 20–30 age group. This research analyses the high prevalence of cardiovascular disease co-morbidities and demonstrates that a high BMI is the most common risk factor for PCOS. The findings of our study indicate the necessity of evaluating the complications seen in individuals who are at risk, such as infertility. This line of research demonstrates the critical impact that medication and lifestyle modifications play in managing PCOS. Patients with the polycystic ovarian syndrome should get advice regarding lifestyle modifications from a clinical pharmacist.
Details
- Language :
- English
- ISSN :
- 28232550
- Volume :
- 3
- Issue :
- 2
- Database :
- Directory of Open Access Journals
- Journal :
- Cellular, Molecular and Biomedical Reports
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.5504b543cebb4ba5bf8ea2dccfe2f195
- Document Type :
- article
- Full Text :
- https://doi.org/10.55705/cmbr.2023.374547.1086